glp-1 agonist mechanism Frontiers Glucagon-like peptide 1 receptor agonists:

Understanding these mechanisms could help manage dyslipidemia and cardiovascular risk [62]

the magnitude of such effect was much lower than of multi-agonists (Suppl

A drug may show strong weight-loss results and still need careful review for heart effects, mood changes, nutrition problems, or long-term risks

Several GLP-1s are beneficial to heart health, but some patients report a slightly elevated heart rate while on them

metformin, sulfonylureas, TZDs, etc.) address only one of the underlying pathophysiology - lowering postprandial glucose levels, but their safety profiles and side effects, such as weight gain and hypoglycemia, may present challenges and limitations in their clinical use